NSEUpdatesResults8 Aug 2026
Par Drugs and Chemicals Limited
Updates
Par Drugs and Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting dated 08.08.2026'. The meeting of Board of Directors considered and approved the Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2026. The Board also approved the drafts of advertisements to be published in newspapers regarding the Unaudited Standalone Financial Results. Additionally, the Board took note of Investor grievances report and reviewed the SCORES platform of SEBI to solve the investor compliant till date. The Board also approved the Corporate Governance Report of the Company for the quarter ended 30th June, 2026. Furthermore, the Board considered and approved the Policy on Communication between Statutory Auditor and Those Charged with Governance (TCWG).
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults8 Aug 2026
Krishna Institute of Medical Sciences Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Krishna Institute of Medical Sciences Limited has announced its Q1 FY '27 earnings, with revenue of INR 1,196 crore, a growth of 36.1% year-on-year and 10.3% on quarter-on-quarter basis. EBITDA was INR 240 crore, with a growth of 20.1% year-on-year and 10.9% on quarter-on-quarter basis. PAT was INR 37 crores, with a growth of 11.8% year-on-year and a decline of 9.1% on quarter-on-quarter basis.
NSEOutcome of Board MeetingResults8 Aug 2026
Par Drugs and Chemicals Limited
Outcome of Board Meeting
Par Drugs and Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026. The meeting of Board of Directors of the Company considered, approved and took on record the Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2026 along with Limited Review Report given CA Mira! Mehta, Partner of Sarupria Somani & Associates, Chartered Accountants, Statutory Auditor of the Company. The Board also considered and approved the drafts of advertisements to be published in newspapers regarding Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults8 Aug 2026
Suyog Telematics Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Suyog Telematics Limited has informed the Exchange about a scheduled post-earnings conference call for Q1 FY 2026-27 on August 12, 2026.
NSEOutcome of Board MeetingResults8 Aug 2026
PNC Infratech Limited
Outcome of Board Meeting
PNC Infratech Limited has announced the outcome of its board meeting, which included the approval of unaudited financial results for the quarter ended June 30, 2026, reappointment of statutory auditors, and reappointment of managing directors and independent directors.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults8 Aug 2026
Western Carriers (India) Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Western Carriers (India) Limited has informed the Exchange about the schedule of a meet to discuss Q1 FY27 earnings conference call.
NSEPress Release▲ PositiveResults8 Aug 2026
Lumax Industries Limited
Press Release
Lumax Industries Limited has announced its unaudited financial results for the first quarter ended June 30, 2026, with a 32.6% year-on-year growth in revenue and a 33.7% year-on-year growth in EBITDA. The company has also made new launches during the quarter and has been awarded several certifications.
NSEPress Release▲ PositiveResults8 Aug 2026
Captain Polyplast Limited
Press Release
Captain Polyplast Limited has reported its unaudited financials for Q1 FY27, with a 16.3% YoY growth in total income and a 26.7% YoY surge in EBITDA. The company has also secured an order worth ₹11.8 crore from MSEDCL for 500 solar pumps under the PM-KUSUM Scheme and commenced production at its new 70,000 sq. ft. manufacturing facility near Ahmedabad, Gujarat.
NSEOutcome of Board MeetingResults8 Aug 2026
Par Drugs and Chemicals Limited
Outcome of Board Meeting
Par Drugs and Chemicals Limited has announced its unaudited standalone financial results for the quarter ended June 30, 2026, and has approved the same at its board meeting. The company has also approved various other matters, including availing forward booking banking facilities, appointing a portfolio manager, and purchasing new motor vehicles for its directors.
NSEShareholders meetingResults8 Aug 2026
Tijaria Polypipes Limited
Shareholders meeting
Tijaria Polypipes Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 07, 2026, and informed the Exchange regarding voting results.
NSEInvestor PresentationResults8 Aug 2026
Advanced Enzyme Technologies Limited
Investor Presentation
Advanced Enzyme Technologies Limited has informed the Exchange about Investor Presentation, enclosed is the Earnings Presentation for the quarter ended June 30, 2026. Revenue grew by 2% on y-o-y basis to ₹ 1,859 million in Q1 FY27 from ₹ 1,859 million in Q1 FY26. EBITDA de-grew by 10% to ₹ 510 million in Q1 FY27 from ₹ 632 million in Q4 FY26. PAT decreased to ₹ 386 million in Q1 FY27 from ₹ 453 million in Q4 FY26.
NSEGeneral UpdatesResults8 Aug 2026
HMA Agro Industries Limited
General Updates
HMA Agro Industries Limited has informed the Exchange about General Updates regarding the disclosure of inter-se transfer of shares among the Promoter and Promoter Group pursuant to Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NSEOutcome of Board MeetingResults8 Aug 2026
Windsor Machines Limited
Outcome of Board Meeting
Windsor Machines Limited has announced the outcome of its Board meeting, where the financial results for the quarter ended June 30, 2026, were considered and approved. The company has also submitted its unaudited standalone and consolidated financial results for the quarter, along with the Limited Review Reports.
NSEUpdatesResults8 Aug 2026
Bigbloc Construction Limited
Updates
Bigbloc Construction Limited has informed the Exchange regarding Earnings Presentation in respect of Unaudited Financial Results of the Company for the Quarter ended June 30, 2026.
NSEPress ReleaseResults8 Aug 2026
Advanced Enzyme Technologies Limited
Press Release
Advanced Enzyme Technologies Limited has announced its unaudited financial results for the first quarter ended June 2026, with revenue from operations growing by 2% year-on-year to ₹1,898 million and EBITDA margin standing at 27%. The company's profit after tax de-grew by 5% to ₹386 million, and earnings per share stood at ₹3.31.
NSEOutcome of Board MeetingResults8 Aug 2026
PNC Infratech Limited
Outcome of Board Meeting
PNC Infratech Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has also re-appointed its statutory auditors, managing directors, and independent directors, and fixed the date for its 27th Annual General Meeting.
NSEAllotment of SecuritiesResults8 Aug 2026
Tracxn Technologies Limited
Allotment of Securities
Tracxn Technologies Limited has informed the Exchange regarding allotment of 6442 securities pursuant to ESOP/ESPS at its meeting held on August 08, 2026. The equity shares so allotted shall rank pari passu with the existing equity shares of the Company. The paid-up share capital of the Company shall stand increased as under: Existing paid up share capital 10,69,18,589; Post Allotment paid up share capital 10,69,25,031.
NSEShareholders meetingResults8 Aug 2026
MM Forgings Limited
Shareholders meeting
MM Forgings Limited held its 80th Annual General Meeting on August 8, 2026, through video conferencing, where the necessary quorum was present and the meeting was in order. The company adopted the audited standalone and consolidated financial statements and reports for the financial year ended March 31, 2026, and appointed two new directors and ratified the remuneration of the cost auditor.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults8 Aug 2026
Akums Drugs and Pharmaceuticals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Presentation for Q1 FY27 Investor Meet/Con. Call Updates. The company has registered a healthy revenue growth of over 13% with EBIDTA increasing by more than 30%. The acquisition of Oriflame India's Manufacturing business is expected to expand the company's manufacturing footprint in skincare cosmetics and wellness products.
NSEOutcome of Board MeetingResults8 Aug 2026
Banco Products (I) Limited
Outcome of Board Meeting
Banco Products (India) Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors also approving the appointment of a new director and cost auditor, and scheduling the 65th Annual General Meeting for September 19, 2026.